TDOC Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Turnaround Efforts TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage LYB Q1 2026 Earnings Strong EPS Surprise of 140 as Cost Optimization Drives Results RLGT Q1 2026 Earnings EPS Surpasses Estimates with 659 Beat GAIA Q1 2026 Earnings EPS Misses Estimates Amidst Transition Stock Rises 5 FRMEP Q1 2026 Earnings Preferred Shares Exceed Expectations with 895 EPS Surprise